6539 Stock Overview
Manufactures and sells medical-grade skin care products in Taiwan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
DV Biomed Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$65.10 |
| 52 Week High | NT$158.50 |
| 52 Week Low | NT$65.10 |
| Beta | 0.24 |
| 1 Month Change | -2.54% |
| 3 Month Change | -5.24% |
| 1 Year Change | -53.68% |
| 3 Year Change | -60.88% |
| 5 Year Change | -54.93% |
| Change since IPO | -72.31% |
Recent News & Updates
Recent updates
How Does DV Biomed Co., Ltd. (GTSM:6539) Stand Up To These Simple Dividend Safety Checks?
Mar 22
DV Biomed Co., Ltd.'s (GTSM:6539) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 27
DV Biomed's (GTSM:6539) Earnings Are Growing But Is There More To The Story?
Jan 07Should DV Biomed (GTSM:6539) Be Disappointed With Their 37% Profit?
Dec 10Are You An Income Investor? Don't Miss Out On DV Biomed Co., Ltd. (GTSM:6539)
Nov 19Shareholder Returns
| 6539 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | -2.0% | -2.6% | -2.1% |
| 1Y | -53.7% | -0.8% | 25.6% |
Return vs Industry: 6539 underperformed the TW Biotechs industry which returned -0.8% over the past year.
Return vs Market: 6539 underperformed the TW Market which returned 25.6% over the past year.
Price Volatility
| 6539 volatility | |
|---|---|
| 6539 Average Weekly Movement | 3.3% |
| Biotechs Industry Average Movement | 4.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6539 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6539's weekly volatility has decreased from 9% to 3% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | n/a | www.dvbiomed.com |
DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company provides health and slimming services; and acts as an agent of medical beauty fillers and medical beauty equipment. It also offers health food, including light and energy drinks; face care; and beauty products and services.
DV Biomed Co., Ltd. Fundamentals Summary
| 6539 fundamental statistics | |
|---|---|
| Market cap | NT$1.34b |
| Earnings (TTM) | NT$52.67m |
| Revenue (TTM) | NT$1.46b |
25.5x
P/E Ratio0.9x
P/S RatioIs 6539 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6539 income statement (TTM) | |
|---|---|
| Revenue | NT$1.46b |
| Cost of Revenue | NT$771.66m |
| Gross Profit | NT$690.03m |
| Other Expenses | NT$637.36m |
| Earnings | NT$52.67m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.55 |
| Gross Margin | 47.21% |
| Net Profit Margin | 3.60% |
| Debt/Equity Ratio | 0% |
How did 6539 perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yield153%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 05:19 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DV Biomed Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|